HUTCHMED Initiates a Japan Bridging Study to Support Surufat

HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors

HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors

wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Japan , Japanese , , Japanese Pharmaceuticals , European Medicines Agency , Drug Administration , Devices Agency , Medical Devices Agency , Marketing Authorization Application , சீனா , ஜப்பான் , ஜப்பானிய , ஜப்பானிய மருந்துகள் , சந்தைப்படுத்தல் அங்கீகாரம் விண்ணப்பம் ,